Track topics on Twitter Track topics that are important to you
62 Fourth Ave
United States of America
NeuroMetrix has ceded ownership of its Quell technology for markets outside the US to Glaxo's consumer health care division
NeuroMetrix has obtained a milestone payment worth $3.8 million from GlaxoSmithKline Consumer Healthcare after it met the fir -More-
GlaxoSmithKline has made a second milestone payment, valued at $3.8 million, to NeuroMetrix under an agreement reached in Jan -More-
NeuroMetrix (Nasdaq:NURO) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,004,445. The patent covers novel technology that enhances DPNCheck® device performance by ...
NeuroMetrix is a science-based health care company transforming patient care through neurotechnology. To date, our focus has been primarily on the assessment of neuropathies. We a...
NeuroMetrix, Inc. was founded in June 1996 as a spin-off from the Harvard-M.I.T. Division of Health Sciences and Technology. The Company’s mission is to: Create value for our customers by developi...
We have published hundreds of NeuroMetrix news stories on BioPortfolio along with dozens of NeuroMetrix Clinical Trials and PubMed Articles about NeuroMetrix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroMetrix Companies in our database. You can also find out about relevant NeuroMetrix Drugs and Medications on this site too.
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...